The lowest rates of recurrent disease and/or death of disease were reported for cases with a p.G12C-alteration and for tumors with morphologic characteristics of MLA and a KRAS-wild-type status in patients with endometrial tumors (Fig. 2). The gene discussed is KRAS; the disease is endometrium neoplasm.